Clinical research,
built better for all.

Today, clinical research is broken.

Inequitable. Fragmented. Inefficient. Costly.

We're building the platform of tomorrow and changing the paradigm for patient care. A new, efficient ecosystem where less physician burden translates to wider patient access and accelerated study timelines. Our mission is to create equitable access to the best possible care for any patient anywhere.

Get the latest on our launch and stay in touch with us.

Sign up

AdobeStock_85674771

GettyImages-1330481753

GettyImages-644187477 (2) (2)

GettyImages-1131369293

Who we are

Meet Our Leadership Team

Kent Thoelke

Kent Thoelke

Chief Executive Officer

Jonathan Hirsch

Jonathan Hirsch

Chief Strategy & Growth Officer

Jay Trepanier

Jay Trepanier

Chief Financial Officer

Elijah Meerson

Elijah Meerson

Chief Technology Officer

Michelle Lee

Michelle Lee

Chief Operating Officer

Board of Directors

Robert Nelsen

Co-founder and Managing Director, ARCH Venture Partners

Hemant Taneja

CEO and Managing Director, General Catalyst

Stephen Knight, MD

President and Managing Partner, F-Prime

Kenneth C. Frazier

Kenneth C. Frazier

Former Executive Chairman & CEO, Merck

General Gustave F. Perna

General (Ret) Gustave F. Perna

Former COO, Operation Warp Speed

Stephen Klasko, MD MBA

Former CEO, Jefferson Health

Luciana Borio, MD

Former Chief Scientist, U.S. Food & Drug Administration

Elena Viboch

Partner, General Catalyst

Kent Thoelke

CEO, Paradigm

Our investors include:

Leading funds backing our vision of a completely new healthcare and drug development paradigm

archventurepartners@2x

FPrime black

Lux Capital

Mubadala Capital

ACS BrightEdge

Tagline

Feature one